Biontech and Medigene want to develop cancer immunotherapies together

TCR therapies are among the cancer immunotherapies that aim to activate the body’s defense system in such a way that it can recognize and destroy cancer cells. In this therapy, doctors remove T cells from the immune system from the patient, genetically modify them so that they recognize the cancer cells as hostile, and give them back to the patient.